中华护理杂志 ›› 2022, Vol. 57 ›› Issue (9): 1094-1099.DOI: 10.3761/j.issn.0254-1769.2022.09.010
收稿日期:
2021-08-13
出版日期:
2022-05-10
发布日期:
2022-05-12
通讯作者:
闫荣,E-mail: 1668725663@qq.com作者简介:
孟祥敏:男,本科(硕士在读),E-mail: 18863672812@163.com
MENG Xiangmin(), WANG Qian, YAN Rong(), LIN Yuting, DING Min
Received:
2021-08-13
Online:
2022-05-10
Published:
2022-05-12
摘要:
目前结直肠癌患者的生存时间已逐渐延长,但癌症及治疗会对其带来诸多困扰。结直肠癌患者报告结局注重患者身心体验的评估,有助于医护人员发现其健康困扰,给予针对性处理。该文综述了国内外结直肠癌领域主要的患者报告结局评估工具及其临床应用情况,比较分析了现有工具的内容特点、存在的问题,提出了未来的研究方向,以期为国内结直肠癌患者报告结局评估工具的应用、开发及临床实践提供参考依据。
孟祥敏, 王倩, 闫荣, 林雨婷, 丁敏. 结直肠癌患者报告结局评估工具及临床应用的研究进展[J]. 中华护理杂志, 2022, 57(9): 1094-1099.
MENG Xiangmin, WANG Qian, YAN Rong, LIN Yuting, DING Min. Research progress on assessment tools of patient-reported outcomes for colorectal cancer patients and the clinical application[J]. Chinese Journal of Nursing, 2022, 57(9): 1094-1099.
[1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
DOI URL |
[2] | Zhang SW, Sun KX, Zheng RS, et al. Cancer incidence and mortality in China,2015[J]. J Natl Cancer Cent, 2021,1(1):2-11. |
[3] | van Cutsem E, De Gramont A, Henning G, et al. Improving outcomes in patients with CRC:the role of patient reported outcomes-an ESDO report[J]. Cancers (Basel), 2017,9(6):E59. |
[4] |
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research,U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research,U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry:patient-reported outcome measures:use in medical product development to support labeling claims:draft guidance[J]. Health Qual Life Outcomes, 2006, 4:79.
DOI URL |
[5] |
Miura Y, Ando M, Yamazaki K, et al. Time-dependent discrepancies between physician-assessed and patient-reported oxaliplatin-induced peripheral neuropathy in patients with metastatic colorectal cancer who received mFOLFOX6 plus bevaci-zumab:a post hoc analysis(WJOG4407GSS2)[J]. Support Care Cancer, 2021, 29(7):3715-3723.
DOI PMID |
[6] |
Carli F, Bousquet-Dion G, Awasthi R, et al. Effect of multimodal prehabilitation vs postoperative rehabilitation on 30-day postoperative complications for frail patients undergoing resection of colorectal cancer:a randomized clinical trial[J]. JAMA Surg, 2020, 155(3):233-242.
DOI URL |
[7] |
Ooki A, Morita S, Iwamoto S, et al. Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer:results of phaseⅡ QUACK trial[J]. Cancer Med, 2020, 9(5):1779-1789.
DOI URL |
[8] | 黄跃师, 朱豫琪, 杨瑒, 等. 医护人员对患者报告结局认知和态度的质性研究[J]. 护士进修杂志, 2021, 36(12):1117-1123. |
Huang YS, Zhu YQ, Yang Y, et al. Cognition and attitude of Chinese medical staff on patient-reported outcomes:a qualitative study[J]. J Nurses Train, 2021, 36(12):1117-1123. | |
[9] |
Dawson J, Doll H, Fitzpatrick R, et al. The routine use of patient reported outcome measures in healthcare settings[J]. BMJ, 2010, 340:c186.
DOI URL |
[10] | McNair AG, Whistance RN, Forsythe RO, et al. Synthesis and summary of patient-reported outcome measures to inform the development of a core outcome set in colorectal cancer surgery[J]. Colorectal Dis, 2015, 17(11):O217-O229. |
[11] |
Dueck AC, Mendoza TR, Mitchell SA, et al. Validity and reliability of the US national cancer institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events(PRO-CTCAE)[J]. JAMA Oncol, 2015, 1(8):1051-1059.
DOI URL |
[12] |
Yang SS, Chen L, Liu Y, et al. Validity and reliability of the simplified Chinese Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events[J]. BMC Cancer, 2021, 21(1):860.
DOI URL |
[13] | Basch E, Dueck AC, Rogak LJ, et al. Feasibility of implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a multicenter trial:NCCTG N1048[J]. J Clin Oncol, 2018:JCO2018788620. |
[14] |
Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks:2005-2008 J Clin Epidemiol, 2010, 63(11):1179-1194.
DOI URL |
[15] | National Institutes of Health. Intro to PROMIS[EB/OL].(2021-05-10)[2021-08-03]. https://www.healthmeasures.net/explore-mea-surement-systems/promis/intro-to-promis. |
[16] | National Institutes of Health. Scoring Instructions[EB/OL]. [2021-10-03]. https://www.healthmeasures.net/score-and-interpret/calculate-scores/scoring-instructions. |
[17] |
Hedrick TL, Harrigan AM, Thiele RH, et al. A pilot study of patient-centered outcome assessment using PROMIS for patients undergoing colorectal surgery[J]. Support Care Cancer, 2017, 25(10):3103-3112.
DOI PMID |
[18] | 皋文君, 袁长蓉. 患者自我报告结局测量信息系统在国外的应用进展[J]. 中华护理杂志, 2018, 53(11):1401-1405. |
Gao WJ, Yuan CR. Application status of Patient Reported Outcomes Measurement Information System in foreign countries[J]. Chin J Nurs, 2018, 53(11):1401-1405. | |
[19] |
Gujral S, Conroy T, Fleissner C, et al. Assessing quality of life in patients with colorectal cancer:an update of the EORTC quality of life questionnaire[J]. Eur J Cancer, 2007, 43(10):1564-1573.
PMID |
[20] |
Whistance RN, Conroy T, Chie W, et al. Clinical and psychometric validation of the EORTC QLQ-CR 29 questionnaire module to assess health-related quality of life in patients with colorectal cancer[J]. Eur J Cancer, 2009, 45(17):3017-3026.
DOI PMID |
[21] |
Lin JB, Zhang L, Wu DW, et al. Validation of the Chinese version of the EORTC QLQ-CR 29 in patients with colorectal cancer[J]. World J Gastroenterol, 2017, 23(10):1891-1898.
DOI URL |
[22] |
van der Hout A, Neijenhuijs KI, Jansen F, et al. Measuring health-related quality of life in colorectal cancer patients:systematic review of measurement properties of the EORTC QLQ-CR 29[J]. Support Care Cancer, 2019, 27(7):2395-2412.
DOI URL |
[23] |
Blazeby JM, Fayers P, Conroy T, et al. Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC 21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases[J]. Br J Surg, 2009, 96(3):291-298.
DOI PMID |
[24] |
Wolstenholme J, Fusco F, Gray AM, et al. Quality of life in the FOXFIRE,SIRFLOX and FOXFIRE-global randomised trials of selective internal radiotherapy for metastatic colorectal cancer[J]. Int J Cancer, 2020, 147(4):1078-1085.
DOI PMID |
[25] |
Ward WL, Hahn EA, Mo F, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument[J]. Qual Life Res, 1999, 8(3):181-195.
PMID |
[26] |
Yost KJ, Cella D, Chawla A, et al. Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches[J]. J Clin Epidemiol, 2005, 58(12):1241-1251.
PMID |
[27] | 杨铮, 卢玉波, 李云峰, 等. 大肠癌患者生命质量测定量表FACT-C(V4.0)中文版应用评价[J]. 中国组织工程研究与临床康复, 2007, 11(43):8753-8756. |
Yang Z, Lu YB, Li YF, et al. Evaluation of the Functional Assessment of Cancer Therapy-Colorectal(V4.0) in Chinese version[J]. J Clin Rehabilitative Tissue Eng Res, 2007, 11(43):8753-8756. | |
[28] |
Drury A, Payne S, Brady AM. Identifying associations between quality of life outcomes and healthcare-related variables among colorectal cancer survivors:a cross-sectional survey study[J]. Int J Nurs Stud, 2020, 101:103434.
DOI URL |
[29] | 杨铮, 卢玉波, 万崇华, 等. 癌症患者生命质量测定量表体系之大肠癌量表QLICP-CR的研制[J]. 癌症, 2008, 27(1):96-100. |
Yang Z, Lu YB, Wan CH, et al. Development of the system of Quality of Life Instruments for Cancer Patients:Colorectal Cancer(QLICP-CR)[J]. Chin J Cancer, 2008, 27(1):96-100. | |
[30] | 刘敏. 辽宁省结直肠癌患者住院费用和生命质量及其影响因素研究[D]. 沈阳: 中国医科大学, 2019. |
Liu M. Research on hospitalization expenses and quality of life of colorectal cancer patients in Liaoning province and their influencing factors[D]. Shenyang: China Medical University, 2019. | |
[31] | 杨铮. 癌症患者生命质量测定量表共性模块(V2.0)研制及最小临床有意义差异制定[D]. 广州: 南方医科大学, 2015. |
Yang Z. Development of the general module of the system of Quality of Life Instruments for Cancer Patients(V2.0) and estimation of its minimal clinically important difference[D]. Guangzhou: Southern Medical University, 2015. | |
[32] |
Colwell HH, Mathias SD, Turner MP, et al. Psychometric evaluation of the FACT Colorectal Cancer Symptom Index:reliability,validity,responsiveness,and clinical meaningfulness[J]. Oncologist, 2010, 15(3):308-316.
DOI PMID |
[33] |
Temple LK, Bacik J, Savatta SG, et al. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer[J]. Dis Colon Rectum, 2005, 48(7):1353-1365.
DOI URL |
[34] | 侯晓婷, 庞冬, 路潜, 等. 肠道功能问卷中文版在直肠癌保肛术后患者中的信效度研究[J]. 中华护理杂志, 2014, 49(12):1453-1458. |
Hou XT, Pang D, Lu Q, et al. Reliability and validity of the MSKCC Bowel Function Instrument in a sample of Chinese rectal cancer patients undergoing sphincter-preserving surgery[J]. Chin J Nurs, 2014, 49(12):1453-1458. | |
[35] |
Yoon BJ, Oh HK, Lee J, et al. Effects of probiotics on bowel function restoration following ileostomy closure in rectal cancer patients:a randomized controlled trial[J]. Colorectal Dis, 2021, 23(4):901-910.
DOI URL |
[36] |
Juul T, Ahlberg M, Biondo S, et al. International validation of the Low Anterior Resection Syndrome Score[J]. Ann Surg, 2014, 259(4):728-734.
DOI URL |
[37] |
Al-Saidi AMA, Verkuijl SJ, Hofker S, et al. How should the Low Anterior Resection Syndrome Score be interpreted[J]. Dis Colon Rectum, 2020, 63(4):520-526.
DOI PMID |
[38] |
Hou XT, Pang D, Lu Q, et al. Validation of the Chinese version of the Low Anterior Resection Syndrome Score for measuring bowel dysfunction after sphincter-preserving surgery among rectal cancer patients[J]. Eur J Oncol Nurs, 2015, 19(5):495-501.
DOI URL |
[39] | 熊燕. Miles术后患者不适反应自我报告量表的构建及其应用研究[D]. 南昌: 南昌大学, 2020. |
Xiong Y. Construction and application of Self-Reporting Scale for Patients with Miles Postoperative Discomfort[D]. Nanchang: Nanchang University, 2020. | |
[40] | 王攀峰, 胡佳慧, 张洪君, 等. 结构化护理风险评估与记录系统的构建与应用[J]. 中华护理杂志, 2018, 53(6):717-719. |
Wang PF, Hu JH, Zhang HJ, et al. Construction and application of the structured nursing risk assessment and recording system[J]. Chin J Nurs, 2018, 53(6):717-719. |
[1] | 吴月红, 梁红霞, 席芳, 李成, 李莹莹, 贾育萌, 郑云云, 冯珍珍. 体外膈肌起搏预防无创机械通气患者膈肌功能障碍的效果研究[J]. 中华护理杂志, 2022, 57(9): 1029-1034. |
[2] | 王子安, 刘欣, 张茜, 俞梦盈, 郑贝贝, 陆骏, 陈婷婷. 经皮冠状动脉介入治疗术后患者恐动症水平变化轨迹研究[J]. 中华护理杂志, 2022, 57(9): 1035-1041. |
[3] | 邓雁, 余琼, 武福姣, 方亮. 基于自我效能理论的护理干预对食管癌根治术后患者的影响[J]. 中华护理杂志, 2022, 57(9): 1042-1047. |
[4] | 成磊, 钱佳艺, 段明霞, 黄海英, 王颖雯. 专业照护者感知的癌症患儿向成人过渡影响因素的质性研究[J]. 中华护理杂志, 2022, 57(9): 1048-1053. |
[5] | 孙艳霞, 李莹, 刘明月, 郭丹丹, 李敏. 宫颈癌患者性健康护理培训方案的构建[J]. 中华护理杂志, 2022, 57(9): 1054-1060. |
[6] | 胡丽莎, 彭红华, 米元元, 曹咪, 胡敏, 祝玲, 喻红君, 彭淑华. 肿瘤靶向治疗患者皮肤不良反应预防及管理的证据总结[J]. 中华护理杂志, 2022, 57(9): 1061-1069. |
[7] | 孙倩倩, 叶红芳, 杨莉. 接纳与承诺疗法对乳腺癌患者干预效果的Meta分析[J]. 中华护理杂志, 2022, 57(9): 1070-1078. |
[8] | 李静, 侯云霞, 强万敏. 癌症患者非计划性再入院风险预测模型的范围综述[J]. 中华护理杂志, 2022, 57(9): 1079-1087. |
[9] | 苏闪闪, 郑蔚, 王丹丹, 刘梦丽, 刘贺, 瞿小凤, 张苇. 癌症患者社会疏离的概念分析[J]. 中华护理杂志, 2022, 57(9): 1088-1093. |
[10] | 周红琴, 陈秀萍, 诸纪华, 夏姗姗, 金陈娣, 盛美君, 罗飞翔, 谢王芳, 左泽兰, 胡静, 刘丽丽, 浦凯. 儿科ICU护士对每日唤醒患儿的知信行现状调查[J]. 中华护理杂志, 2022, 57(9): 1100-1104. |
[11] | 蒋琪霞, 唐永利, 洪艳燕, 匡丹, 王静, 展颖颖, 潘迎春, 高艳红, 郝景平, 陈锐, 刘海燕, 俞萍, 蔡蕴敏, 黄玲, 王祖晶. 50所医院老年患者皮肤损伤现状及危险因素分析[J]. 中华护理杂志, 2022, 57(9): 1105-1112. |
[12] | 贾红红, 刘丽, 罗小茜, 周郁秋. 认知-预警干预对农村糖尿病治疗延误患者的效果研究[J]. 中华护理杂志, 2022, 57(9): 1113-1119. |
[13] | 张毅, 汪健健, 邓艳红, 陈章群, 罗姜, 彭德珍, 赵丽萍. 护士人文素养自评量表的研制及信效度检验[J]. 中华护理杂志, 2022, 57(9): 1120-1128. |
[14] | 吴海燕, 王淑芹, 郭琪, 张春艳, 贾燕瑞, 孙兵. 1例肾病综合征合并肺孢子菌及巨细胞病毒肺炎患者的护理[J]. 中华护理杂志, 2022, 57(9): 1129-1133. |
[15] | 张晓梅, 秦毅, 陈瑜, 王伶俐, 李静逸, 王娅. 经中心静脉通路装置采血的最佳证据总结[J]. 中华护理杂志, 2022, 57(9): 1134-1140. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||